1. Home
  2. BWEN vs VRCA Comparison

BWEN vs VRCA Comparison

Compare BWEN & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$3.98

Market Cap

105.8M

Sector

Industrials

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.43

Market Cap

107.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWEN
VRCA
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.8M
107.5M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
BWEN
VRCA
Price
$3.98
$5.43
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$6.00
$17.00
AVG Volume (30 Days)
388.8K
28.8K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
360.00
N/A
EPS
N/A
N/A
Revenue
$146,785,000.00
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17.37
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$1.88
$3.28
52 Week High
$5.52
$9.82

Technical Indicators

Market Signals
Indicator
BWEN
VRCA
Relative Strength Index (RSI) 41.04 45.47
Support Level $3.75 $5.32
Resistance Level $4.15 $6.53
Average True Range (ATR) 0.51 0.39
MACD -0.07 -0.05
Stochastic Oscillator 6.02 32.21

Price Performance

Historical Comparison
BWEN
VRCA

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. The company provides technologically high-value products to customers with complex systems and stringent quality standards that operate in the energy, mining, and infrastructure sectors in the United States of America. Its capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treatment, CNG decompression, precision machining, assembly, engineering, and packaging solutions, among others. The company operates in four reportable segments: Heavy Fabrications, which generates the maximum revenue, Gearing, Industrial Solutions, and Corporate.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: